MMP9 and renal cell carcinoma: Additionally, the Akt activator SC79, could remarkably reverse the inhibitory effect of migration and invasion by Tet in RCC, accompanied with the restoration of NF-κB and MMP-9 protein levels (S2A–S2D Fig).